Corvi Federico, Souied Eric H, Falfoul Yousra, Georges Anouk, Jung Camille, Querques Lea, Querques Giuseppe
Department of Ophthalmology, University Paris Est Creteil, Centre Hospitalier Intercommunal de Creteil, Creteil, France.
Department of Ophthalmology, University Vita-Salute, IRCCS Ospedale San Raffaele, Milan, Italy.
Br J Ophthalmol. 2017 Jun;101(6):770-773. doi: 10.1136/bjophthalmol-2016-309115. Epub 2016 Sep 1.
To investigate the response of carotenoid supplementation in different phenotypes of early age-related macular degeneration (AMD) by measuring macular pigment optical density (MPOD) and retinal sensitivity.
Consecutive patients with only medium/large drusen and only reticular pseudodrusen (RPD) and age-matched and sex-matched controls were enrolled. At baseline, participants underwent a complete ophthalmological examination including measurement of best-corrected visual acuity (BCVA), MPOD and retinal sensitivity. Patients were put on vitamin supplementation (lutein 10 mg/day, zeaxanthin 2 mg/day) and 3 months later underwent a repeated ophthalmological examination.
Twenty patients with medium/large drusen, 19 with RPD and 15 control subjects were included. At baseline, in controls, mean MPOD and BCVA were significantly higher compared with RPD (p=0.001 and p=0.01) but similar to medium/large drusen (p=0.9 and p=0.4). Mean retinal sensitivity was significantly higher in controls compared with RPD and medium/large drusen (for all p<0.0001). After 3 months of carotenoid supplementation the mean MPOD significantly increased in RPD (p=0.002), thus showing no more difference compared with controls (p=0.3); no significant changes were found in mean retinal sensitivity and BCVA (p=0.3 and p=0.7). Medium/large drusen did not show significant changes on MPOD, retinal sensitivity and BCVA (p=0.5, p=0.7 and p=0.7, respectively).
Patients with early AMD, especially RPD phenotype, show lower macular sensitivity and MPOD than controls. After supplementation, MPOD significantly increased in RPD. These results suggest different pathophysiology for RPD as compared with medium/large drusen and may open new ways to identifying further therapeutic targets in this phenotype of early AMD.
通过测量黄斑色素光密度(MPOD)和视网膜敏感度,研究补充类胡萝卜素对不同表型的早期年龄相关性黄斑变性(AMD)的反应。
纳入仅患有中度/大型玻璃膜疣和仅患有网状假性玻璃膜疣(RPD)的连续患者以及年龄和性别匹配的对照组。在基线时,参与者接受全面的眼科检查,包括测量最佳矫正视力(BCVA)、MPOD和视网膜敏感度。患者接受维生素补充(叶黄素10毫克/天,玉米黄质2毫克/天),3个月后再次接受眼科检查。
纳入20例患有中度/大型玻璃膜疣的患者、19例患有RPD的患者和15例对照受试者。在基线时,与RPD相比,对照组的平均MPOD和BCVA显著更高(p = 0.001和p = 0.01),但与中度/大型玻璃膜疣相似(p = 0.9和p = 0.4)。与RPD和中度/大型玻璃膜疣相比,对照组的平均视网膜敏感度显著更高(所有p < 0.0001)。补充类胡萝卜素3个月后,RPD组的平均MPOD显著增加(p = 0.002),因此与对照组相比不再有差异(p = 0.三);平均视网膜敏感度和BCVA未发现显著变化(p = 0.3和p = 0.7)。中度/大型玻璃膜疣在MPOD、视网膜敏感度和BCVA方面未显示出显著变化(分别为p = 0.5、p = 0.7和p = 0.7)。
早期AMD患者,尤其是RPD表型患者,黄斑敏感度和MPOD低于对照组。补充后,RPD组的MPOD显著增加。这些结果表明,与中度/大型玻璃膜疣相比,RPD的病理生理学不同,可能为识别这种早期AMD表型的进一步治疗靶点开辟新途径。